Details
Stereochemistry | ACHIRAL |
Molecular Formula | CH4N2O.H2O2 |
Molecular Weight | 94.0699 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OO.NC(N)=O
InChI
InChIKey=AQLJVWUFPCUVLO-UHFFFAOYSA-N
InChI=1S/CH4N2O.H2O2/c2-1(3)4;1-2/h(H4,2,3,4);1-2H
Molecular Formula | CH4N2O |
Molecular Weight | 60.0553 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | H2O2 |
Molecular Weight | 34.0147 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Hydrogen peroxide has been used in medicine for more than 100 years. It is known in surgery as a highly useful irrigation solution by virtue of both its hemostatic and its antimicrobial effects. Hydrogen peroxide is a mild antiseptic used on the skin to prevent infection of minor cuts, scrapes, and burns. It may also be used as a mouth rinse to help remove mucus or to relieve minor mouth irritation (e.g., due to canker/cold sores, gingivitis). This product works by releasing oxygen when it is applied to the affected area. The release of oxygen causes foaming, which helps to remove dead skin and clean the area. Hydrogen peroxide is a strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0016491 Sources: http://adisinsight.springer.com/drugs/800039206 |
|||
Target ID: O94759 Gene ID: 7226.0 Gene Symbol: TRPM2 Target Organism: Homo sapiens (Human) |
4.54 null [pEC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | ESKATA Approved UseESKATA is indicated for the treatment of seborrheic keratoses that are raised. Launch Date1.51312322E12 |
|||
Preventing | Hydrogen Peroxide Solution Approved UseUses of Hydrogen Peroxide Solution:
It is used to prevent skin infections.
It is used to help get rid of phlegm or mucus or help with a sore mouth. |
|||
Primary | Hydrogen Peroxide Solution Approved UseHydrogen peroxide is a mild antiseptic used on the skin to prevent infection of minor cuts, scrapes, and burns. It may also be used as a mouth rinse to help remove mucus or to relieve minor mouth irritation (e.g., due to canker/cold sores, gingivitis). Launch Date4.10140803E11 |
PubMed
Title | Date | PubMed |
---|---|---|
Critical role of sulfenic acid formation of thiols in the inactivation of glyceraldehyde-3-phosphate dehydrogenase by nitric oxide. | 1999 Jul 1 |
|
Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. | 2000 Mar |
|
Involvement of lipoxygenase in lysophosphatidic acid-stimulated hydrogen peroxide release in human HaCaT keratinocytes. | 2000 Mar 15 |
|
The super anti-apoptotic factor Bcl-xFNK constructed by disturbing intramolecular polar interactions in rat Bcl-xL. | 2000 Nov 24 |
|
Role of heme oxygenase-1 in the regulation of manganese superoxide dismutase gene expression in oxidatively-challenged astroglia. | 2000 Oct |
|
Roles of oxygen radical production and lipid peroxidation in the cytotoxicity of cephaloridine on cultured renal epithelial cells (LLC-PK1). | 2000 Sep |
|
Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. | 2000 Sep |
|
Phospholipase D2 activity suppresses hydrogen peroxide-induced apoptosis in PC12 cells. | 2000 Sep |
|
Simultaneous measurement of ERK, p38, and JNK MAP kinase cascades in vascular smooth muscle cells. | 2000 Sep-Oct |
|
Mitochondrial-derived oxidants and quartz activation of chemokine gene expression. | 2001 |
|
Repression of GADD153/CHOP by NF-kappaB: a possible cellular defense against endoplasmic reticulum stress-induced cell death. | 2001 Apr 19 |
|
Manganese superoxide dismutase signals matrix metalloproteinase expression via H2O2-dependent ERK1/2 activation. | 2001 Apr 27 |
|
Reactive carbonyl formation by oxidative and non-oxidative pathways. | 2001 Aug 1 |
|
Thioredoxin peroxidase-1 (peroxiredoxin-1) is increased in thioredoxin-1 transfected cells and results in enhanced protection against apoptosis caused by hydrogen peroxide but not by other agents including dexamethasone, etoposide, and doxorubicin. | 2001 Aug 1 |
|
NF kappa B and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells. | 2001 Dec 1 |
|
Repression of phenobarbital-dependent CYP2B1 mRNA induction by reactive oxygen species in primary rat hepatocyte cultures. | 2001 Jun |
|
Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. | 2001 Nov 30 |
|
Reactive oxygen species mediate cyclic strain-induced endothelin-1 gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in endothelial cells. | 2001 Oct |
|
Acetaminophen induces apoptosis of C6 glioma cells by activating the c-Jun NH(2)-terminal protein kinase-related cell death pathway. | 2001 Oct |
|
Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. | 2002 Apr |
|
High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. | 2002 Aug |
|
Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. | 2002 Feb 15 |
|
Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts. | 2002 Jul |
|
Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929. | 2002 Jul 15 |
|
Reversible inactivation of the tumor suppressor PTEN by H2O2. | 2002 Jun 7 |
|
Glucose-6-phosphate dehydrogenase: the key to sex-related xenobiotic toxicity in hepatocytes of European flounder (Platichthys flesus L.)? | 2002 Mar |
|
Protein overload-induced NF-kappaB activation in proximal tubular cells requires H(2)O(2) through a PKC-dependent pathway. | 2002 May |
|
Differential expression of two stress-inducible hsp70 genes by various stressors. | 2002 May 31 |
|
Mechanisms of the genotoxicity of crocidolite asbestos in mammalian cells: implication from mutation patterns induced by reactive oxygen species. | 2002 Oct |
|
Iron augments stage-I and stage-II tumor promotion in murine skin. | 2002 Sep 26 |
|
The antioxidant cocktail effective microorganism X (EM-X) inhibits oxidant-induced interleukin-8 release and the peroxidation of phospholipids in vitro. | 2002 Sep 6 |
Sample Use Guides
Topical solution: 40% (w/w) hydrogen peroxide. Apply 4 times, approximately 1 minute apart, to the
targeted lesion(s) during a single in-office treatment
session.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23537657
Hydrogen peroxide (H2O2, 100-500 uM) caused a concentration-dependent decrease in the activity of recombinant mouse 3-MST enzyme. In mitochondria isolated from murine hepatoma cells, H2O2 (50-500 uM) caused a concentration-dependent decrease in production of H2S from 3-MP. In cultured murine hepatoma cells H2O2, (3-100 uM), did not result in overall cytotoxicity, but caused a partial decrease in basal oxygen consumption and respiratory reserve rapacity. The positive bioenergetic effect of 3-MP (100-300 nM) was completely abolished by pre-treatment of the cells with H2O2 (50 uM).
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 19:57:40 UTC 2023
by
admin
on
Sat Dec 16 19:57:40 UTC 2023
|
Record UNII |
31PZ2VAU81
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C28394
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
||
|
CFR |
21 CFR 344.10
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C009096
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
PRIMARY | |||
|
DTXSID9024726
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
PRIMARY | |||
|
SUB15664MIG
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
PRIMARY | |||
|
24852
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
PRIMARY | |||
|
4445
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
PRIMARY | |||
|
47686
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
PRIMARY | RxNorm | ||
|
C77033
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
PRIMARY | |||
|
204-701-4
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
PRIMARY | |||
|
Hydrogen peroxide - urea
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
PRIMARY | |||
|
Carbamide Peroxide
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
PRIMARY | |||
|
75178
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
PRIMARY | |||
|
124-43-6
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
PRIMARY | |||
|
31PZ2VAU81
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
PRIMARY | |||
|
31PZ2VAU81
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
PRIMARY | |||
|
DB11129
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
PRIMARY | |||
|
m3054
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000088234
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
PRIMARY | |||
|
31294
Created by
admin on Sat Dec 16 19:57:40 UTC 2023 , Edited by admin on Sat Dec 16 19:57:40 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |